Paddington Testing Company

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Psoriasis1 trial

Phase

• Phase 11 trial
• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Biosion, Inc.1 trial
• Bristol-Myers Squibb1 trial
• Pfizer1 trial

Running trials

• Recruiting

  A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

  NCT06979453· Phase 3· Bristol-Myers Squibb· Source

  Contact: Jennifer Parish, Site 0073

• Recruiting

  FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

  NCT06564389· Phase 1· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)1 recruiting
• Psoriasis1 recruiting

Closed trials

• Completed

  POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis

  NCT05932654· Phase 2· Biosion, Inc.· Source